Want to create an interactive transcript for this episode?
Podcast: Medsider: Learn from Medtech and Healthtech Founders and CEOs
Episode: Why Commercial Discipline Starts Long Before Launch: Interview with RenovoRx CEO Shaun Bagai
Description: In this episode of Medsider Radio, we sat down with Shaun Bagai, CEO of RenovoRx. The company is developing targeted oncology therapies and is currently commercializing RenovoCath, which is focused on pancreatic cancer. Before joining RenovoRx in 2014, Shaun spent over a decade in the cardiovascular space, including leading global market development at HeartFlow and helping establish the European renal denervation market at Ardian, which Medtronic acquired for approximately $1 billion. He began his career in clinical research and device sales at TransVascular and Medtronic. In this interview, Shaun discusses how testing markets with min...